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Infectious  salmon  anemia  virus  (ISAV)  is  a piscine  orthomyxovirus,  which  causes  multisystemic  disease
in farmed  Atlantic  salmon  that may  result  in large  losses.  Previous  work  has suggested  that  ISAV is  able  to
resist  the  antiviral  state  induced  in  cells  by  type  I interferon  (IFN). These  studies  were,  however,  mainly
based  on  cytopathic  effect  (CPE)  reduction  assays.  Here  we have  investigated  the  antiviral  activity  of
Atlantic salmon  IFNa1,  IFNb  and IFNc  against  ISAV  using  quantitative  PCR  (qPCR)  of segment  6, Western
blot  analysis  of ISAV  proteins  and  viral  yield  reduction  assays,  in  addition  to CPE reduction  assays.  Antiviral
effects  of  IFNs  were  tested  against  the  high  virulent  strain  ISAV4  and  the  low  virulent  strain  ISAV7  both  at
the optimum  growth  temperature  15 ◦C  and  at 20 ◦C.  As  expected,  IFNa1  showed  little  protection  against
CPE  development  in  cells  after  infection  with  both  strains  at 15 ◦C. However,  the  qPCR  and  Western  blot
analysis  clearly  showed  strong  inhibition  of  replication  of the  virus  strains  by IFNa1  between  24 and  72 h
after  infection.  The  inhibitory  effect  declined  four to  ﬁve  days  post-infection,  which  explains  the  low
◦SAV protection  against  CPE  development  7–10 days  later.  At 20 C, IFNa1  showed  strong  protection  against
CPE  development,  probably  due  to slower  virus  growth.  IFNc  showed  similar  antiviral  activity  as  IFNa1
against  ISAV4  while  IFNb  showed  lower  activity.  There  were  observed  differences  between  ISAV4  and
ISAV7  both  with  respect  inhibition  by  IFNa1  and  ability  to  induce  the  two  IFN-inducible  antiviral  effector
proteins,  Mx  and  ISG15,  which  may  be  related  to differences  in virulence  properties  and/or  adaption  to
growth in  cell  culture.
 201©
. Introduction
Infectious salmon anemia virus (ISAV) is a piscine orthomyx-
virus of the Isavirus genus, which causes a multisystemic disease
n farmed Atlantic salmon (Salmo salar L.) (Falk et al., 1997; Krossøy
t al., 1999). Like the inﬂuenza A virus, ISAV is enveloped and has a
enome composed of eight linear, single-stranded RNA segments of
egative polarity (Mjaaland et al., 1997). The eight segments give
ise to a total of ten proteins where segment 6 (s6) encodes the
urface glycoprotein haemagglutinin–esterase (HE) (Cottet et al.,
011; Krossøy et al., 2001; Rimstad et al., 2001).
Type I interferons (IFNs) play a crucial role in the ﬁrst line of
efense against viruses in vertebrates. The type I IFNs are cytokines
Abbreviations: ASK, Atlantic salmon kidney cells; CPE, cytopathic effect; HE,
aemagglutinin–esterase; IFN, interferon; ISAV, infectious salmon anemia virus;
SG, interferon stimulated gene; NP, nucleoprotein; PKR, protein kinase R.
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with antiviral activity, which are produced and secreted after recog-
nition of viral nucleic acid by host pathogen recognition receptors
such as TLR3, TLR7 and RIG-I-like receptors. Secreted IFN binds
and signals through the IFN-receptor (IFNAR) expressed on the
surface of host cell, and activation of IFNAR leads to upregu-
lation of hundreds of interferon stimulated genes (ISGs). Many
ISG-products, such as ISG15 and Mx,  have direct antiviral effects
and collectively induce an antiviral state in the cell (Sadler and
Williams, 2008; Takeuchi and Akira, 2007). In Atlantic salmon, four
different subtypes of type I IFN have been reported, and these
are encoded by one to several genes: IFNa (three genes), IFNb
(four genes), IFNc (ﬁve genes) and IFNd (one gene) (Sun et al.,
2009; Svingerud et al., 2012). IFNa1, IFNb and IFNc have been
conﬁrmed to have antiviral activity against IPNV and to induce sev-
eral ISGs including Mx,  ISG15, ISG58, viperin and protein kinase
R (PKR), whereas IFNd does not display antiviral activity against
IPNV and does not induce Mx  protein (Svingerud et al., 2012).
Atlantic salmon IFNa1 has previously also been demonstrated to
have antiviral activity of against salmonid alphavirus 3 (Xu et al.,
Open access under CC BY-NC-ND license.2010). Pretreatment of Atlantic salmon TO cells with recombi-
nant IFNa1 did, however, not inhibit ISAV-induced CPE, whereas
a modest reduction in CPE was  observed in SHK-1 cells (Jensen and
Robertsen, 2002; Kileng et al., 2007). Intraperitoneal injection of
icense.
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tlantic salmon with the potent inducer of type I IFNs, polyinosinic
olycytidylic acid, has however been shown to reduce the cumula-
ive mortality of ISAV-infected ﬁsh compared to control ﬁsh (Jensen
t al., 2002).
Two ISAV strains were used in the present study, ISAV4
Glesvaer/2/90) and ISAV7 (ISAV96/09/1729). These strains have
een reported as high- and low-virulent, respectively, based on the
ortality obtained in challenge experiments with Atlantic salmon
Mjaaland et al., 2005). Both viruses have a lysine in position 266 of
he fusion protein and close to identical HE sequences (Markussen
t al., 2008), which are two traits that have been linked to viru-
ence (Markussen et al., 2008; Mjaaland et al., 2005; Plarre et al.,
012). The ability to antagonize the IFN system is known to play
 part in virulence in other viral strains, such as Inﬂuenza A virus
Jackson et al., 2008; Li et al., 2006b), but if this also applies to
SAV is at the present not known. However, two proteins named
7ORF1 and s8ORF2, have been shown to inhibit activation of the
almon IFNa1 promoter, and the rainbow trout Mx promoter (only
7ORF1) (García-Rosado et al., 2008; McBeath et al., 2006). s7ORF1
nd s8ORF2 from ISAV4 differ from those of ISAV7 by several amino
cids (Markussen et al., 2008), but whether these sequence differ-
nces can explain difference in strain virulence is unknown.
The main objective of the present paper was to establish if IFNa1
ould induce antiviral activity against ISAV in salmon cells by the
se of several different antiviral assays. We  also wanted to test if
FNa1, IFNb and IFNc showed differences in antiviral activity against
SAV. Finally, we studied whether ISAV4 and ISAV7 showed differ-
nces in sensitivity to the antiviral state induced by IFNa1 and if
he two viruses showed differences in ability to induce the antiviral
enes Mx  and ISG15 in salmon cells.
. Materials and methods
.1. Cells and viruses
ASK cells derived from Atlantic salmon head kidney (Devold
t al., 2000) were purchased from American Type Culture Collec-
ion. ASK and TO cells (Wergeland and Jakobsen, 2001) were grown
t 20 ◦C in L-15 medium (Gibco) containing 1× MEM  Non-Essential
mino Acid Solution (Invitrogen), 100 U/ml penicillin, 100 g/ml
treptomycin and 15% (ASK) or 8% (TO) FBS Superior (Biochrom
G).
The ISAV4 (Glesvaer/2/90) and ISAV7 (ISAV96/09/1729) isolates,
hich originate from ISA outbreaks in Norway (Mjaaland et al.,
005), were obtained from the Norwegian Veterinary Institute,
slo. Virus propagation was performed in ASK cells, whereas viral
iters were determined by endpoint titration in TO cells. Infec-
ion was carried out by absorbing the viral suspension to the cells
n serum-free medium for 3 h before removing the medium and
dding L-15 containing 2.5% serum. Infection and post-infection
ncubation were carried out at 15 ◦C in most experiments, with the
xception of the CPE reduction assays, which were performed both
t 15 ◦C and 20 ◦C, and the experiments comparing the antiviral
ffect of IFNa1, IFNb and IFNc, which were carried out only at 20 ◦C.
nless otherwise stated a multiplicity of infection (MOI) of 1 was
pplied.
.2. Interferons
Recombinant Atlantic salmon IFNa1 (GenBank accession no.
Q354152.1), IFNb (GenBank accession no. JX524152) and IFNc
GenBank accession no. JX524153) were produced by transfec-
ion of HEK-293 cells with IFN expression plasmids as described
Svingerud et al., 2012). The IFN yields were estimated to be
50,000, 5700, 8,200,000 U/ml, respectively, where 1 unit (U) of IFNrch 177 (2013) 163– 170
activity was deﬁned as the reciprocal dilution of the supernatant
causing 50% reduction in IPNV-induced CPE in ASK cells. In the vari-
ous experiments, the IFNs were diluted in L-15 medium containing
15% FBS Superior and supplements before addition to cells. IFNb
shows the highest amino acid sequence identity (99.5%) to the pre-
viously described IFNb2 sequence, while the IFNc sequence is most
similar to IFNc1 (99.5%) (Sun et al., 2009; Svingerud et al., 2012).
2.3. Antibodies
The rabbit anti-ISAV HE antibody was generous gift from
Dr. Anita Müller (University of Tromsø) (Müller et al., 2008).
Mouse anti-ISAV nucleoprotein antibody (clone 2C2/H4) was from
Immunological and biochemical testsystems GmbH. Rabbit anti-
salmon Mx1  antibody was  made against recombinant Atlantic
salmon Mx1  protein in our laboratory by Dr. Hilde Hansen. The
rabbit anti-ISG15 is described in Røkenes et al. (2007). The rab-
bit anti-actin antibody was obtained from Sigma–Aldrich, whereas
the secondary antibodies, goat anti-rabbit-horseradish peroxidase
and goat anti-mouse-horseradish peroxidase were from Santa Cruz
Biotechnology.
2.4. CPE reduction assay
The CPE reduction assay was performed as described earlier
with some modiﬁcations (Berg et al., 2009). Brieﬂy, ASK cells were
seeded in 96-well plates at 25,000 cells per well. The following day,
the IFNa1 batch was diluted in L-15 medium containing 15% FBS
and supplements, and various concentrations (1000, 500, 200, 50
and 5 U/ml) were added onto the cells at 100 l per well (n = 4).
After 24 h, the IFNa1-containing medium was removed and the cells
were infected with ISAV4 or ISAV7 (Section 2.1). Untreated control
cells, infected and uninfected, were included. When complete CPE
was observed in untreated control cells, the cells were stained with
crystal violet, dissolved in 50% ethanol containing 0.05 M sodium
citrate and the absorbance was  read at 550 nm.  To compare the
antiviral effect of IFNa1, IFNb and IFNc, a similar experiment was
performed using ISAV4 and 500, 50 and 5 U/ml of each IFN.
2.5. Inhibition of ISAV replication by IFN, and induction of Mx  by
ISAV4 and ISAV7 (qPCR)
Replication of ISAV4 and ISAV7, and the inhibiting effect of IFNa1
were determined by studying the levels of ISAV s6 RNA using qPCR.
ASK cells were seeded in 24-well plates at 1.5 × 105 cells per well
and treated with 1000 U/ml of IFNa1 in 1 ml  of medium the fol-
lowing day or mock-treated (control). The cells were infected with
ISAV4 or ISAV7 after 24 h of treatment by replacing the medium
with medium containing virus. Cells from triplicate wells were har-
vested at 4, 24, 72 and 120 h post-inoculation for RNA isolation and
qPCR analyses (Section 2.6). The mock-treated samples from the
72 h time point were also used to determine the induction of Mx
gene expression by ISAV4 and ISAV7. To compare the antiviral effect
of IFNa1, IFNb and IFNc, ASK cells were treated with 1000 U/ml of
each IFN or left untreated (n = 3). After 24 h the cells were infected
by ISAV4 as described above. Cells were harvested at 72 h p.i. for
RNA isolation and qPCR analysis.
2.6. RNA isolation, cDNA synthesis and relative qPCR
RNeasy Mini Kit from Qiagen was  used for RNA isolation fol-
lowing the manufacturer’s recommendation. Cells were lysed in
350 l RLT buffer containing 10 l/ml 2-mercapto-ethanol at the
indicated time points (Section 2.5), and the samples were homoge-
nized using a 0.9 mm needle connected to a syringe. cDNA synthesis
was performed with the QuantiTect Rev. Transcription Kit (Qiagen)
T. Svingerud et al. / Virus Resea
Table 1
Primers used for qPCR.
Primer name Sequence
18S rRNA forward 5‘-TGTGCCGCTAGAGGTGAATT-3‘
18S rRNA reverse 5‘-GCAAATGCTTTCGCTTTCG-3‘
ISAV-s6 forward 5‘-GAAGCAGATGAGTGGAAGGTTTC-3‘
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dISAV-s6 reverse 5‘-CCGTCAGTGCAGTCATTGGT-3‘
Mx-  forward 5‘-TGCAACCACAGAGGCTTTGAA-3‘
Mx-reverse 5‘-GGCTTGGTCAGGATGCCTAAT-3‘
sing 150 ng total RNA. PCR was performed in a 15 l reaction mix-
ure containing 6.1 l 1:10 dilution of cDNA (except for detection
f 18S rRNA, where a 1:1000 dilution was applied), 7.5 l Fast SYBR
reen Master Mix  (Applied Biosystems) and 230 nM of forward and
everse primers (Table 1). The qPCR was run in triplicate wells on
 7500 Fast Real Time PCR system (Applied Biosystems), and the
CR program was as follows: 1 cycle of 95 ◦C for 20 s followed by
0 cycles of 95 ◦C for 3 s and 60 ◦C for 30 s. A melt curve stage was
ncluded to conﬁrm the absence of primer–dimers and nonspeciﬁc
roducts. The relative expression of ISAV s6 and Mx  was normalized
gainst the expression of 18S rRNA as described (Kileng et al., 2007).
old-increase of s6 was calculated relative to the ISAV4-infected
FNa1-treated 4 h time point (set to 1), while fold-upregulation of
x was calculated relative to uninfected untreated cells. In the
xperiments comparing the effect of IFNa1, IFNb and IFNc, the
pregulation of s6 was calculated relative to the untreated infected
ontrol cells.
.7. Viral yield reduction assay
ASK cells were seeded in 24-well plates at 1.5 × 105 cells per
ell and treated with 1000 U/ml in 1 ml  medium of IFNa1 or
edium (control) the following day. The IFN-containing medium
as removed after 24 h and the cells were infected with ISAV4 or
SAV7. Supernatants from triplicate wells were harvested for virus
itration 72 h post-infection, which were determined by end-point
itration in TO cells using the TCID50 method (Reed and Muench,
938). The antiviral effect of IFNa1, IFNb and IFNc against ISAV4 was
ompared in a similar experiment using 1000 U/ml of each IFN.
.8. Western blot analysis
To study the inhibitory effect of IFNa1 against ISAV4 and ISAV7
E protein production, and to determine the effect of virus infec-
ion on Mx  expression, ASK cells were seeded in 24-well plates at
.5 × 105 per well, and treated with 1000 U/ml IFNa1 or medium
controls). The cells were infected with ISAV4 or ISAV7 24 h later,
nd harvested 24, 48, 72, 96 and 120 h post-infection in 70 l SDS
ample buffer. SDS-PAGE was performed using 10 l of each sam-
le on a 4–12% NuPAGE Bis–Tris Gel (Invitrogen). The proteins
ere blotted onto PVDF membranes, blocked with 5% dry milk and
ncubated overnight with anti-HE antibody (1:2000) and anti-Mx
ntibody (1:3000) at 4 ◦C followed by 1 h incubation with the sec-
ndary antibody (goat-anti rabbit HRP) at a dilution of 1: 20,000.
he blots were developed using SuperSignal West Pico Chemi-
uminescent Substrate from Pierce, and images were captured on a
odak image station 4000MM pro from Carestream Health, Inc. To
etect actin, the membranes were stripped before being incubated
ith the anti-actin antibody (1:1000) overnight (4 ◦C) followed
y re-incubation with secondary antibody. Stripping of the mem-
ranes was performed by 5 min  incubation with dH2O, 10 min  in
.2 M NaOH, followed by 5 min  wash in dH2O.The inhibitory effects of IFNa1, IFNb and IFNc on production of
SAV4 HE protein and ISAV4 nucleoprotein (NP) were compared
sing 1000 U/ml of each IFN in an otherwise similar experiment. A
ilution of 1:2000 of the anti-NP antibody was applied to detect NP.rch 177 (2013) 163– 170 165
Both goat-anti rabbit HRP and goat-anti mouse HRP were used as
secondary antibodies, at a dilution of 1:20,000 and 1:10,000 respec-
tively. Virus inoculation and the following incubation were carried
out at 20 ◦C, and the samples were harvested only at 72 h p.i. The
net intensity of the NP- and actin bands from triplicate lanes was
measured by Carestream Molecular Imaging software (Version 5.0),
and the NP/actin ratio was calculated. The inhibitory effect of IFNa1,
IFNb and IFNc on ISAV NP production was  presented as the percent
intensity of the NP/actin ratio in the treated cells relative to the
untreated, infected control samples.
The expression of Mx  and ISG15 in ISAV4 and ISAV7-infected
ASK cells were determined by Western blot analyses. ASK cells were
seeded in 24-well plates at 1.5 × 105 per well and infected with
ISAV4 or ISAV7 at a MOI  of 5 the following day. A high virus titer was
used to ensure that all cells were infected. After 24 h, cells were har-
vested and the presence of Mx,  ISAV NP and actin was determined as
described above. In this experiment, the anti-NP antibody was used
at a dilution of 1:500. To detect ISG15, the membrane was stripped
before proceeding to the primary antibody incubation using a dilu-
tion of 1:20,000. The net intensity of Mx,  ISG15 and actin bands run
in triplicate lanes were measured by Carestream Molecular Imaging
software, and the ratio of NP/actin- and ISG15/actin was  calculated.
2.9. Statistical analyses
Unpaired Student’s t-test was used to calculate statistics.
3. Results
3.1. Effect of IFNa1 pretreatment on ISAV4 and ISAV7-induced
CPE
The CPE reduction assay, which is a widely used method to
determine antiviral activity of IFNs, was used to measure the antivi-
ral activity of IFNa1 against the high virulent strain ISAV4 and the
low virulent strain ISAV7 in ASK cells. Stimulation with IFN was
carried out at 20 ◦C, while infections were carried out both at 15 ◦C,
which is the optimal growth temperature of the virus, and at 20 ◦C
where the virus replicates more slowly (Falk et al., 1997). Com-
plete virus-induced CPE was observed in the untreated control cells
8 days after infection for the experiments performed at 15 ◦C and
12 days after infection for the experiments performed at 20 ◦C. As
seen in Fig. 1A and B, pretreatment of ASK cells with IFNa1 induced
a slight protection against ISAV4 (8–9%) and ISAV7-induced CPE
(11–17%) at 15 ◦C. A much higher level of protection was observed
at 20 ◦C (Fig. 1C and D), which is most probably due to slower repli-
cation of the virus at this temperature (Falk et al., 1997). In contrast
to that observed at 15 ◦C, the replication of ISAV4 was  more easily
inhibited by IFNa1 compared to ISAV7 when infections were carried
out at 20 ◦C. Some of the cells in the wells infected with ISAV4 alone
did not reach complete lysis at the termination of the assay at 20 ◦C,
while all the cells infected with ISAV7 were completely lysed, and
the higher inhibition of ISAV4-induced lysis might thus be caused
by a slower replication of ISAV4 than ISAV7 at this temperature.
3.2. Effect of IFNa1 pretreatment on replication of ISAV4 and
ISAV7
The inhibitory effects of IFNa1 pretreatment on the replica-
tion of ISAV4 and ISAV7 at 15 ◦C were studied in a qPCR time
course study of s6 (Fig. 2A and B). The s6 sequences of ISAV4
and ISAV7 are highly similar (Markussen et al., 2008), and the
primer pairs were designed to span areas with 100% match. RNA
was harvested from IFNa1-treated and untreated ISAV-infected
ASK cells at 4, 24, 72 and 120 h post infection (p.i.), and the
fold increase of s6 RNA was for all the samples calculated rela-
tive to the s6 RNA level in the ISAV4-infected IFNa1-treated cells
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t the 4 h p.i. The s6 RNA levels in the 4 h p.i. samples from
oth the untreated ISAV4 and the untreated ISAV7-infected cells
ere 1.6-fold higher than this calibration sample, which conﬁrms
hat comparable amounts of ISAV4 and ISAV7 had infected the
ells.
The two strains showed a similar replication rate with a fold
ncrease of s6 RNA of 118,000 (ISAV4) and 126,000 (ISAV7) at
20 h p.i. in untreated cells (Fig. 2A and B). Pretreatment of cells
ith IFNa1 inhibited the replication of both viruses, with a fold-
eduction of 1.4–8.4 at the various time points. The antiviral effect
f IFNa1 was most prominent at 24 and 72 h p.i., and the fold-
ifference between the treated and untreated cells was declining
or both strains at 120 h p.i. (Fig. 2A and B). The replication of
SAV7 was, however, slightly more inhibited by IFNa1 at 120 h
.i. compared to that of ISAV4 (2.4-fold versus 1.3-fold reduction,
espectively).
The effect of IFNa1 pretreatment on replication of ISAV4 and
SAV7 was also determined at the translational level by Western
lot analysis of ISAV HE protein in IFN-treated and untreated cells
Fig. 2C and D). In the untreated samples, ISAV4 and ISAV7 HE were
etectable from 48 h and displayed strong expression from 72 h.
or both strains, IFNa1 strongly inhibited HE production at 48 and
2 h p.i., but the viral protein was increasing at 96 h p.i. and showed
 high expression at 120 h p.i.
The expression of host antiviral Mx  protein was also analyzed
n the same experiment. IFNa1 induced expression of Mx  in ASK
ells already at 24 h post-treatment, and a high Mx  expression
as seen throughout the 120 h experimental period. Interestingly,
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ISAV7 induced increasing Mx  protein levels at 24, 48 and 72 h p.i.
in untreated cells (Fig. 2D), whereas little Mx  was observed in the
ISAV4-infected cells at any of the time points (Fig. 2C).
To measure the effect of IFNa1 on the viral yields, the medium
supernatants from the 72 h qPCR samples were collected and the
viral titers were determined by the TCID50 method. As illustrated
in Fig. 2E and F, pretreatment of cells with IFNa1 caused a 37-
fold and 12-fold reduction in viral yields of ISAV4 and ISAV7,
respectively.
3.3. Comparison of the antiviral activity of IFNa1, IFNb and IFNc
against ISAV4
The antiviral activity of IFNa1, IFNb and IFNc against ISAV4 was
compared by four different methods: CPE reduction assay, qPCR of
s6 RNA, Western blot analysis of HE and NP, and reduction in viral
yields (Fig. 3). Due to the low antiviral activity of IFNa1 against
ISAV in the CPE reduction assay at 15 ◦C (Fig. 1A), virus infected
cells were incubated at 20 ◦C in these experiments. For the qPCR
and Western blot analyses, ASK cells were pretreated with IFN for
24 h prior to infection with ISAV4, and the samples were harvested
at 72 h p.i. The CPE reduction assay was terminated when control
cells reached complete CPE.
Fig. 3A shows that pretreatment of ASK cells with all three
IFNs inhibited ISAV4-induced CPE. IFNa1 and IFNc showed simi-
lar antiviral potency, inducing 75–80% cell survival at the highest
doses, whereas the IFNb-induced cell survival was 25–30 percent-
age points lower.
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Fig. 2. IFNa1-induced inhibition of ISAV4 and ISAV7. ASK cells were treated with 1000 U/ml IFNa1 or left untreated, and infected with ISAV4 or ISAV7 24 h later (MOI 1). RNA
levels  of ISAV4 (A) and ISAV7 (B) s6 were determined 4, 24, 72 and 120 h p.i. by qPCR. The expression was normalized against 18S rRNA and the fold upregulation of both
strains was calculated relative to the s6 transcript levels in the IFNa1-treated ISAV4-infected cells at 4 h p.i. The mean values from triplicate wells ±SD are given, and the
numbers above the lines represent the fold difference between IFNa1-treated and untreated cells. For Western blot analyses, ASK cells were left untreated or pretreated with
1000  U/ml IFNa1 24 h prior to infection with (C) ISAV4 or (D) ISAV7 (MOI 1). Samples were harvested at 24, 48, 72, 96 and 120 h post infection, and the expression of Mx,
actin  and ISAV HE was detected. C; control samples (untreated uninfected cells). The supernatants from the 72 h qPCR time points (panel A and B) were harvested and viral
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2.7-fold higher level of Mx  and a 2.9-fold higher level of ISG15
than ISAV4. Finally, the induction of Mx  gene expression by ISAV4iters  of ISAV4 (E) and ISAV7 (F) were assessed by endpoint titration. The titers we
he  mean values ± SD. The numbers above the bars give the fold difference between
arried out at 15 ◦C for all the experiments.
The effect of IFN pretreatment on ISAV replication was further
ompared by studying the RNA levels of ISAV4 s6 in IFN-treated and
ntreated ISAV4-infected ASK cells using qPCR (Fig. 3B). Pretreat-
ent with IFNa1, IFNb and IFNc reduced the ISAV4 s6 RNA levels
.4-, 1.7- and 3.9-fold relative to untreated cells, respectively.
Western blot analyses revealed that all three IFNs also inhibited
xpression of ISAV4 HE and (Fig. 3C) NP (Fig. 3D) proteins. IFNa1
xhibited the highest inhibitory effect on NP and HE production
ollowed by IFNc and IFNb, respectively. The protein samples were
un in three parallel wells (not shown), and the net intensities of the
P and actin-bands were measured on a Kodak image station. The
P band intensities were normalized against the intensity of the
espective actin bands, and the percent reduction in the NP bands
y IFNa1, IFNb and IFNc relative to untreated control samples was
etermined. IFNa1 reduced the NP band intensity by 93%, IFNb by
7% and IFNc by 89% (Fig. 3E).
Finally, it was determined that IFNa1, IFNb and IFNc inhibited
he viral yields of ISAV4 8-, 2- and 7-fold, respectively
Fig. 3F).ermined individually from each of the three parallel wells, and the bars represent
ock-treated and IFN-treated cells. Virus inoculation and following incubation were
3.4. Induction of Mx and ISG15 protein by ISAV4 and ISAV7
The ﬁnding that ISAV7 induced Mx  protein more strongly than
ISAV4 (Fig. 2C and D) inspired us to examine the Mx and ISG15
protein-induction by the two  ISAV strains. ASK cells were infected
with ISAV4 and ISAV7, and samples were harvested 24 h p.i. A
MOI  of 5 was  used to ensure that most cells were synchronously
infected at an early time point after virus inoculation. As seen
in Fig. 4A and B, ISAV7 induced higher protein levels of both
Mx and ISG15 than ISAV4. Very similar levels of ISAV NP were
expressed, indicating that comparable amounts of ISAV4 and
ISAV7 had infected the cells. To obtain quantitative data, the net
intensities of the Mx-, ISG15- and actin-bands from three parallel
wells were measured, and the Mx/actin and ISG15/actin ratios
were calculated. As displayed in Fig. 4C and D, ISAV7 induced aand ISAV7 was compared by qPCR (Fig. 4E). At 72 h p.i., ISAV4 and
ISAV7 upregulated the Mx  transcript levels 180- and 270-fold,
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Fig. 3. Comparison of antiviral activity of IFNa1, IFNb and IFNc against ISAV4 in ASK cells. (A) CPE reduction assay. ASK were treated with various concentrations of IFN (n = 4)
and  infected with ISAV4 24 h later at a MOI  of 1. When untreated control cells showed complete CPE, cell survival was estimated by crystal violet staining (optical density
at  550 nm). (B) qPCR: ASK cells were treated with 1000 U/ml of IFNa1, IFNb and IFNc or left untreated (n = 3) and infected with ISAV4 (MOI = 1) 24 h later. RNA was  sampled
72  h p.i. and the s6 RNA levels were determined by qPCR. (C) Western blot: ASK cells were treated with 1000 U/ml of the indicated IFNs, and infected with ISAV4 (MOI 1) 24 h
later.  The cells were harvested 72 h p.i., and the expression of NP and actin was  analyzed. (D) Western blot analysis of ISAV HE was run on the samples presented in panel C.
(E)  The net intensities of the Western blot NP- and actin bands from three parallel wells were quantiﬁed, and the NP/actin ratio was calculated. The bars show the percent
reduction in NP/actin ratio in the IFN-treated cells relative to untreated infected controls. (F) Supernatants from the qPCR experiment (panel B) were harvested at 72 h p.i.,
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lnd  the viral yields were determined by end-point titration in TO cells. The three r
ollowing incubation was  performed at 20 ◦C. For panel A, B, E and F the mean value
espectively, compared to untreated control cells. Taken together,
hese results suggests that ISAV7 induces the antiviral proteins Mx
nd ISG15 more potently than ISAV4 in ASK cells.
. Discussion
The present work demonstrates that Atlantic salmon IFNa1
nduces antiviral activity in ASK cells against both the high
irulent strain ISAV4 and the low virulent strain ISAV7. How-
ver, at 15 ◦C, which is the optimal growth temperature of the
irus, the antiviral effect was most pronounced at 24–72 h after
nfection, whereas the inhibitory effect seemed to decline four
o ﬁve days after infection (Fig. 2A–D). This transient inhibition
ossibly explains why only a slight protection was observed in the
PE reduction assay at 15◦, as it takes 8 days to reach complete
SAV-induced lysis of the cells. This may  also be the reason why
ittle antiviral activity of salmon IFN was observed in previouste wells were titrated independently. In all the experiments virus inoculation and
 are given.
works, which only studied antiviral activity of IFN using the
CPE reduction assay (Jensen and Robertsen, 2002; Kileng et al.,
2007)
The transient antiviral effect of IFNa1 against ISAV could
be a consequence of increasing levels of viral IFN antagonistic
proteins as the viral replication progresses and/or degradation
of IFN-induced proteins. The expression of viral proteins that
limit the effects of antiviral proteins is well known from other
orthomyxoviruses such as Inﬂuenza A and B. For example, the
non-structural protein 1 (NS1) of inﬂuenza A is known to block
the activation of PKR (Li et al., 2006a), whereas the NS1 protein
of Inﬂuenza B has been demonstrated to inhibit the ISGylation
process by interacting with ISG15 (Yuan and Krug, 2001). Among
the ISAV proteins, s7ORF1 and s8ORF2 have been demonstrated
to inhibit activation of the salmon IFNa1 promoter (García-Rosado
et al., 2008), whereas s7ORF1 also inhibits the induction of the
Mx promoter (McBeath et al., 2006). It is not known at present if
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fter  ISAV4 and ISAV7-infection (MOI 1) in ASK cells by qPCR. Fold increase was  c
*p  < 0.01; *p < 0.07. In all the experiments the infection and incubation was carried
ne or both of these proteins also inhibit the function of antiviral
roteins, but this is an interesting subject for future studies. A
igh turnover rate of certain IFN-induced antiviral proteins might
lso explain the observed transient effect of IFNa1. This does not
nclude Mx  protein, which was strongly expressed at each time
oints in the virus-infected cells pretreated with IFNa1 (Fig. 2C and
). Mx  proteins are, however, known to be particularly stable due
o their ability to form large stabilizing aggregates (Haller et al.,
007). Other antiviral proteins are less stable, and the half-life of
uman PKR is for instance just 6.6 h (Liu et al., 2007).
In this work we also compared the antiviral activity of IFNa1,
FNb and IFNc against ISAV4. IFNd was not included, since this IFN
ubtype has previously been demonstrated to not confer antivi-
al activity against IPNV (Svingerud et al., 2012). IFNa1 and IFNc
howed similar antiviral activity against ISAV4 in the CPE reduc-
ion assay and in the viral yield reduction assay, whereas IFNc
isplayed a slightly lower ability to reduce s6 RNA levels and HE
nd NP protein levels than IFNa. By contrast, IFNb displayed less
ntiviral activity than both IFNa1 and IFNc in all assays (Fig. 3).
he higher antiviral effect of IFNa/IFNc compared to IFNb is in
greement with earlier work, where Atlantic salmon IFNa1 and
FNc displayed higher antiviral activity than IFNb against IPNV
Svingerud et al., 2012). In zebraﬁsh, IFNa (IFN1) and IFNc (IFN2
nd IFN3) homologs signal via two different receptors (Aggad
t al., 2009; Levraud et al., 2007). As suggested previously, the
ower activity of IFNb may  be due to lower expression of a puta-
ive IFNb receptor compared to putative IFNa and IFNc receptors,
ifferences in the intracellular signaling pathways downstream of
he receptor(s), or lower afﬁnity for an IFN-receptor shared by IFNa,
FNb and IFNc (Svingerud et al., 2012). At present the nature and
umber of type I IFN receptors in Atlantic salmon are, however,
nknown.). Mean values ± SD are given (n = 3). (E) mRNA levels of Mx  were determined 72 h
ted relative to uninfected cells. Mean values ± SD are given (n = 3). Student t test:
 15 ◦C.
The replication of the high virulent ISAV4 and low virulent ISAV7
strains was  inhibited to a similar degree by IFNa1 pretreatment at
24 and 72 h after virus inoculation. However, at 120 h p.i. the repli-
cation of ISAV7 was somewhat more strongly inhibited (2.4-fold
versus 1.3-fold) than that of ISAV4 in the experiments conducted
at 15 ◦C (Fig. 2A and B). By contrast, IFNa1 seemed to inhibit ISAV4
more strongly than ISAV7 when the virus inoculation and the sub-
sequent cell incubation were performed at 20 ◦C (Fig. 1C and D).
Whether these differences in IFN-sensitivity between the two viral
strains play a role in the in vivo virulence of the two strains is
uncertain.
Interestingly, ISAV7 induced about 3-fold higher protein levels
of Mx  and ISG15 than ISAV4 (Fig. 4A–D), and a 1.5-fold higher
induction of Mx  gene transcripts in ASK cells (Fig. 4E). An interesting
subject for future studies is thus to examine if there is a difference
in the IFN-pathway antagonizing properties of ISAV4 compared
to ISAV7. The s7ORF1 proteins of ISAV4 and ISAV7 differ by four
amino acids, whereas the s8ORF2 proteins differ by one amino acid,
and these substitutions might affect the IFN antagonistic activities
of the proteins (Markussen et al., 2008). In contrast to our study,
Schiøtz et al. (2009) reported that ISAV4 induced Mx-  and ISG15
gene expression more strongly (about 1.3-fold) than ISAV7 (Schiøtz
et al., 2009). In both the present study and in the study by Schiøtz
et al., the differences in gene expression between ISAV4 and ISAV7
were thus quite modest. The cause for the discrepancies could be
that the ISAV4 and/or ISAV7 have evolved new traits during in
vitro passaging in one or both of the studies. We did, however,
conﬁrm that the low and high virulent traits of ISAV7 and ISAV4
were still intact; in an in vivo challenge trial, 39 out of 40 Atlantic
salmon presmolts were still alive 27 days after an intraperitoneally
injection with ISAV7 (one thousand particles), while only twelve
out of 40 ﬁsh survived an injection with the same amount of ISAV4
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results not shown). The discrepancies could further be caused by
 difference in the amounts of ISAV4 versus ISAV7 used to infect
he cells in one or both of the studies, which in turn would affect
he virus-induced gene and protein expression. To control that
omparable amounts of ISAV4 and ISAV7 had infected the ASK cells,
e included a 4 h p.i. time point in our qPCR studies (Fig. 2A and
) to monitor the expression of viral s6 RNA early after infection.
hese data suggested that highly comparable levels of ISAV4 and
SAV7 had infected the cells. The virus control in the Western blot
tudies similarly revealed that highly comparable levels of ISAV
P was expressed in the ISAV4 and ISAV7-infected cells 24 h post
nfection (Fig. 4A). Interestingly, a recent study using two  ISAV
trains of European genotype showed that a low virulent ISAV
train upregulated Mx  and other immune- and IFN-related genes to
 higher degree than a high virulent strain (Workenhe et al., 2009).
In conclusion, the present work demonstrates that Atlantic
almon IFNa1, IFNb and IFNc exhibit a strong antiviral activity
gainst ISAV in cell culture at early time points after infection. The
ffect of IFN is transient, which might explain earlier difﬁculties to
rmly demonstrate inhibitory activity against ISAV. There was  not
 consistent difference between high- and low-virulent ISAV4 and
SAV7 strains in their sensitivity to the IFN-induced antiviral state
n vitro, but ISAV4 appear to induce lower levels of Mx  and ISG15
rotein than ISAV7.
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